Standout Papers

Consolidated Health Economic Evaluation Re... 1997 2026 2006 2016 1.5k
  1. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)
    Don Husereau, Michael Drummond et al. Value in Health
  2. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)
    Don Husereau, Michael Drummond et al. BMJ
  3. Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. (1998)
    Ray Fitzpatrick, Mark Sculpher et al. PubMed
  4. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation (1997)
    Andrew Briggs, David Wonderling et al. Health Economics
  5. Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)
    Elisabeth Fenwick, Bernie J. OʼBrien et al. Health Economics
  6. An Introduction to Markov Modelling for Economic Evaluation (1998)
    Andrew Briggs, Mark Sculpher PharmacoEconomics
  7. Handling Uncertainty in Cost-Effectiveness Models (2000)
    Andrew Briggs PharmacoEconomics
  8. Model Parameter Estimation and Uncertainty Analysis (2012)
    Andrew Briggs, Milton C. Weinstein et al. Medical Decision Making
  9. Review of statistical methods for analysing healthcare resources and costs (2010)
    Borislava Mihaylova, Andrew Briggs et al. Health Economics
  10. Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research (2013)
    Richard D Riley, Jill A. Hayden et al. PLoS Medicine
  11. Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report (2005)
    Scott D. Ramsey, Richard J. Willke et al. Value in Health
  12. Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)
    J. Jaime, Andrew Briggs et al. Value in Health
  13. Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)
    Scott D. Ramsey, Richard J. Willke et al. Value in Health
  14. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement (2013)
    Don Husereau, Michael Drummond et al. Value in Health
  15. Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 (2012)
    Andrew Briggs, Milton C. Weinstein et al. Value in Health
  16. Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes (2013)
    Harry Hemingway, Peter Croft et al. BMJ
  17. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)
    Don Husereau, Michael Drummond et al. Value in Health
  18. CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT (2013)
    Don Husereau, Michael Drummond et al. International Journal of Technology Assessment in Health Care
  19. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)
    Don Husereau, Michael Drummond et al. Value in Health
  20. Modeling Good Research Practices—Overview (2012)
    J. Jaime, Andrew Briggs et al. Medical Decision Making
  21. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations (2022)
    Don Husereau, Michael Drummond et al. BMJ
  22. Cardiac Troponin T and Troponin I in the General Population (2019)
    Paul Welsh, David Preiss et al. Circulation
  23. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations (2022)
    Don Husereau, Michael Drummond et al. BMC Medicine
  24. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)
    Don Husereau, Michael Drummond et al. Applied Health Economics and Health Policy

Immediate Impact

1 by Nobel laureates 9 from Science/Nature 64 standout
Sub-graph 1 of 20

Citing Papers

Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030: a retrospective impact evaluation and forecasting analysis
2025 Standout
Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial
2023 Standout

Works of Andrew Briggs being referenced

Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
2012 Standout
Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane
1998

Author Peers

Author Last Decade Papers Cites
Andrew Briggs 10211 5248 3246 4098 408 28.4k
Milton C. Weinstein 11468 6502 2514 4520 348 32.8k
Mark Sculpher 9403 5077 2143 3929 344 24.1k
Miguel A. Hernán 5560 2505 2706 2847 309 40.5k
John Brazier 14701 8817 1472 4914 540 38.2k
Robert H. Brook 7603 9242 2851 2724 350 23.5k
Alex J. Sutton 3483 4130 3364 5609 307 38.8k
Dennis A. Revicki 4487 4167 1672 4229 429 30.2k
E. John Orav 4633 7746 1723 4671 441 32.4k
John Z. Ayanian 7117 7653 2139 3057 346 25.4k
Paula Williamson 4285 2897 2362 3949 489 27.6k

All Works

Loading papers...

Rankless by CCL
2026